The Philippines’ FDA has granted full emergency use authorization to Bharat Biotech’s COVID-19 vaccine Covaxin, The Philippine Star reported.
FDA director general Eric Domingo said the Indian company last week submitted a certificate for good manufacturing practices, a requirement for the importation of its vaccine.
Covaxin is a two-dose inactivated vaccine cleared for use in individuals aged 18 and older. The vaccine was reported to have an efficacy of 77.8% based on data from a Phase III trial.
To read more NewsPoints articles, click here.